N. Oden

发表

Validation of My Family Health Portrait for six common heritable conditions

Leslie G Biesecker, Kandamurugu Manickam, Neal Oden, 2010, Genetics in Medicine.

SCORE Study report 3: study design and baseline characteristics.

Ingrid U Scott, Michael S Ip, Barbara A Blodi, 2009, Ophthalmology (Rochester, Minn.).

Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).

N. Oden, R. Crockett, R. Vogel, 2010, American journal of ophthalmology.

Classification criteria for acute posterior multifocal placoid pigment epitheliopathy.

A. Dick, B. Trusko, D. Jabs, 2021, American journal of ophthalmology.

Development of the Clinical Gestalt Assessment: a visual clinical global impression scale for Proteus syndrome

Julie C. Sapp, L. Biesecker, N. Oden, 2022, Orphanet Journal of Rare Diseases.

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

Julie C. Sapp, L. Biesecker, Julie Harris, 2018, Genetics in Medicine.

Classification criteria for cytomegalovirus retinitis.

Justine R. Smith, B. Trusko, R. V. Van Gelder, 2021, American journal of ophthalmology-glaucoma.

Classification criteria for tubercular uveitis.

Justine R. Smith, B. Trusko, D. Jabs, 2021, American journal of ophthalmology.

SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes with Central or Hemiretinal Vein Occlusion Managed with Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.

I. Scott, N. Oden, B. Blodi, 2020, American journal of ophthalmology.

Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.

I. Scott, Clement K Chan, N. Oden, 2019, JAMA ophthalmology.

Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.

G. Fish, I. Scott, F. Barton, 2019, JAMA ophthalmology.

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

I. Scott, N. Oden, B. Blodi, 2019, JAMA ophthalmology.

Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents

I. Scott, N. Oden, B. Blodi, 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

Classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis.

B. Trusko, D. Jabs, P. Murray, 2021, American journal of ophthalmology.

Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol

R. Mandler, B. Adinoff, A. Forcehimes, 2012, Addiction Science & Clinical Practice.

Familial thyroid disease and delayed language development in first admission patients with schizophrenia

L. DeLisi, A. Hoff, N. Oden, 1991, Psychiatry Research.

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10

I. Scott, N. Oden, B. Blodi, 2011 .

Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)

G. D’Onofrio, M. Pantalon, Shara Martel, 2019, Implementation Science.

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

P. Korthuis, R. Mandler, R. Lindblad, 2017, Addiction.

Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurity.

D. Phelps, R. Engel, N. Oden, 2006, Paediatric and perinatal epidemiology.

Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).

I. Scott, P. V. Van Veldhuisen, N. Oden, 2020, Ophthalmology. Retina.

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

I. Scott, N. Oden, B. Blodi, 2015, JAMA ophthalmology.

Classification criteria for sarcoidosis-associated uveitis.

B. Trusko, A. Denniston, D. Jabs, 2021, American journal of ophthalmology.

Thrombosis risk factors in PIK3CA‐related overgrowth spectrum and Proteus syndrome

Julie C. Sapp, L. Biesecker, K. Keppler-Noreuil, 2019, American journal of medical genetics. Part C, Seminars in medical genetics.

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Kim A. Hoffman, D. McCarty, Elizabeth H. Payne, 2022, Addiction.

Randomized Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results from STimulant Reduction Intervention using Dosed Exercise (CTN-0037; STRIDE)

M. Trivedi, S. Blair, E. Nunes, 2017 .

SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.

I. Scott, N. Oden, B. Blodi, 2009, American journal of ophthalmology.

Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study

J. Klausner, L. Marsch, Haiyi Xie, 2020, JMIR research protocols.

Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study (Preprint)

J. Klausner, L. Marsch, Haiyi Xie, 2020 .

Classification criteria for varicella zoster virus anterior uveitis.

B. Trusko, D. Jabs, P. Murray, 2021, American journal of ophthalmology.

Classification criteria for acute retinal necrosis syndrome.

Justine R. Smith, B. Trusko, R. V. Van Gelder, 2021, American journal of ophthalmology.

Classification criteria for cytomegalovirus anterior uveitis.

B. Trusko, D. Jabs, A. Galor, 2021, American journal of ophthalmology.

Classification criteria for Fuchs uveitis syndrome.

B. Trusko, D. Jabs, P. Murray, 2021, American journal of ophthalmology.

Classification criteria for herpes simplex virus anterior uveitis.

B. Trusko, D. Jabs, P. Murray, 2021, American journal of ophthalmology.

Classification criteria for punctate inner choroiditis.

B. Trusko, D. Jabs, P. McCluskey, 2021, American journal of ophthalmology.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Ingrid U Scott, Michael S Ip, Barbara A Blodi, 2009, Archives of ophthalmology.

Classification criteria for multifocal choroiditis with panuveitis.

B. Trusko, D. Jabs, P. McCluskey, 2021, American journal of ophthalmology.

Classification criteria for serpiginous choroiditis.

B. Trusko, D. Jabs, A. Palestine, 2021, American journal of ophthalmology.

Sensitivity and specificity of a screening questionnaire for dry eye.

F. Ederer, N. Oden, M. Lemp, 1998, Advances in experimental medicine and biology.

Molecular genetic findings and clinical correlations in 100 patients with Joubert syndrome and related disorders prospectively evaluated at a single center

J. Mullikin, I. Glass, Nisc Comparative Sequencing Program, 2017, Genetics in Medicine.

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

I. Scott, N. Oden, B. Blodi, 2011, Ophthalmology.

Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.

D. Phelps, D. Bremer, R. Fellows, 2002, Pediatrics.

Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)

R. Mandler, R. Lindblad, B. Adinoff, 2011, The American journal of drug and alcohol abuse.

A Pulmonary Score for Assessing the Severity of Neonatal Chronic Lung Disease

D. Phelps, N. Oden, A. Madan, 2005, Pediatrics.

Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott–Aldrich Syndrome

F. Candotti, N. Oden, R. Sokolic, 2015, Front. Pediatr..

Classification criteria intermediate uveitis, non-pars planitis type.

A. Dick, B. Trusko, A. Denniston, 2021, American journal of ophthalmology.

Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease.

Z. Quezado, W. Gahl, B. Turkbey, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Testing and linkage to HIV care in China: a cluster-randomised trial.

R. Detels, J. Montaner, W. Ling, 2017, The lancet. HIV.

Classification criteria for Behçet Disease Uveitis.

A. Dick, B. Trusko, D. Jabs, 2021, American journal of ophthalmology.

Classification criteria for birdshot chorioretinitis.

B. Trusko, D. Jabs, P. McCluskey, 2021, American journal of ophthalmology.

Classification criteria for tubulointerstitial nephritis with uveitis syndrome.

B. Trusko, A. Denniston, D. Jabs, 2021, American journal of ophthalmology.

SCORE2 Report 2: Study Design and Baseline Characteristics.

I. Scott, N. Oden, B. Blodi, 2017, Ophthalmology.

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.

I. Scott, N. Oden, B. Blodi, 2009, Ophthalmology.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

C. del Rio, M. Mugavero, L. Metsch, 2016, JAMA.

Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.

Judy E. Kim, I. Scott, P. V. Van Veldhuisen, 2010, Archives of ophthalmology.

Hair analysis and its concordance with self-report for drug users presenting in emergency department.

M. Bogenschutz, N. Oden, P. Vanveldhuisen, 2016, Drug and alcohol dependence.

Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.

D. Simpson, D. Byrd, S. Morgello, 2008, Archives of neurology.

SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.

I. Scott, N. Oden, B. Blodi, 2009, Ophthalmology.

Prevalence of obesity among U.S. population with substance dependence.

N. Oden, P. Vanveldhuisen, B. Tai, 2020, Drug and alcohol dependence.

Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.

M. Trivedi, S. Blair, E. Nunes, 2012, The journal of global drug policy and practice.

Stimulant Reduction Intervention using Dosed Exercise (STRIDE) - CTN 0037: Study protocol for a randomized controlled trial

M. Trivedi, S. Blair, E. Nunes, 2011, Trials.

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.

M. Lyons, L. Metsch, A. Douaihy, 2014, JAMA internal medicine.

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial

I. Scott, C. Awh, N. Oden, 2017, JAMA.

The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.

I. Scott, N. Oden, B. Blodi, 2009, Archives of ophthalmology.

Classification criteria for Sympathetic Ophthalmia.

A. Dick, B. Trusko, D. Jabs, 2021, American journal of ophthalmology.

Classification criteria for Vogt-Koyanagi-Harada Disease.

A. Dick, B. Trusko, A. Denniston, 2021, American journal of ophthalmology.

Development of classification criteria for the uveitides.

B. Trusko, D. Jabs, P. McCluskey, 2021, American journal of ophthalmology.

Classification criteria for pars planitis.

A. Dick, B. Trusko, A. Denniston, 2021, American journal of ophthalmology.

Statistical issues related to early closure of STOP-ROP, a group-sequential trial.

D. Phelps, N. Oden, 2003, Controlled clinical trials.

Classification criteria for multiple evanescent white dot syndrome.

A. Dick, B. Trusko, D. Jabs, 2021, American journal of ophthalmology.

Classification criteria for juvenile idiopathic arthritis-associated chronic anterior uveitis.

B. Trusko, D. Jabs, P. Murray, 2021, American journal of ophthalmology.

Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.

I. Scott, N. Oden, B. Blodi, 2021, JAMA ophthalmology.

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

L. Biesecker, Julie Harris, R. Loffroy, 2018, Genetics in Medicine.

SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.

I. Scott, N. Oden, B. Blodi, 2017, American journal of ophthalmology.

Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.

B. Doft, M. Elman, I. Scott, 2012, Archives of ophthalmology.

Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 1

I. Scott, N. Oden, B. Blodi, 2022, JAMA ophthalmology.

SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type.

I. Scott, N. Oden, B. Blodi, 2009, Ophthalmology.

Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial

I. Scott, N. Oden, B. Blodi, 2018, JAMA ophthalmology.

Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

R. Lindblad, Paul G. Wakim, N. Oden, 2016, Journal of substance abuse treatment.

Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.

M. Trivedi, T. Carmody, S. Blair, 2017, The Journal of clinical psychiatry.

Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials

M. Trivedi, Paul G. Wakim, N. Oden, 2011, The American journal of drug and alcohol abuse.

SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.

I. Scott, N. Oden, B. Blodi, 2023, Ophthalmology.

Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14

I. Scott, K. Eliceiri, N. Oden, 2021, Translational vision science & technology.

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

I. Scott, N. Oden, B. Blodi, 2017, JAMA ophthalmology.

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.

I. Scott, N. Oden, B. Blodi, 2016, American journal of ophthalmology.

Month 60 Outcomes after Treatment Initiation with Anti-VEGF Therapy for Macular Edema due to Central or Hemi-Retinal Vein Occlusion.

I. Scott, N. Oden, B. Blodi, 2022, American journal of ophthalmology.

SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion

I. Scott, N. Oden, B. Blodi, 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

Cluster analysis and genotype-phenotype assessment of geographic atrophy in age-related macular degeneration: AREDS2 Report 25.

E. Agrón, E. Chew, A. Henning, 2021, Ophthalmology. Retina.

SCORE2 Report 2: Study Design and Baseline Characteristics.

I. Scott, N. Oden, B. Blodi, 2017, Ophthalmology (Rochester, Minn.).

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

I. Scott, D. Sarraf, N. Mehta, 2023, Translational vision science & technology.

Visit Adherence and Visual Acuity in Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).

B. Vanderbeek, I. Scott, N. Oden, 2023, Ophthalmic epidemiology.

Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27.

N. Oden, B. Blodi, P. Vanveldhuisen, 2023, JAMA ophthalmology.

Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease.

Z. Quezado, W. Gahl, B. Turkbey, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.

M. Lyons, L. Metsch, A. Douaihy, 2014, JAMA internal medicine.